• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Myriad Genetics Inc

+ Add to Watchlist


33.2900 USD 0.0900 0.27%

As of 09:53:31 ET on 11/28/2014.

Snapshot for Myriad Genetics Inc (MYGN)

Open: 33.3000 Day's Range: 33.2100 - 33.3800 Volume: 43,719
Previous Close: 33.2000 52wk Range: 20.0200 - 42.5000 1-Yr Rtn: +12.13%

Stock Chart for MYGN

No chart data available.
  • MYGN:US 33.2900
  • 1D
  • 1M
  • 1Y
Interactive MYGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYGN

Current P/E Ratio (ttm) 18.2293
Estimated P/E(06/2015) 18.0782
Relative P/E vs. SPX 0.9949
Earnings Per Share (USD) (ttm) 1.8267
Est. EPS (USD) (06/2015) 1.8420
Est. PEG Ratio 1.1813
Market Cap (M USD) 2,430.41
Shares Outstanding (M) 72.99
30 Day Average Volume 853,689
Price/Book (mrq) 3.4189
Price/Sale (ttm) 3.3181
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYGN

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

Peter D MeldrumPresident/CEO/Co-FounderRobert Gardner HarrisonChief Information Officer
R Bryan RiggsbeeExec VP/CFO/TreasurerJerry S LanchburyChief Scientific Officer
More Company Profile & Key Executives for MYGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil